Profile

Helen Vosper
Title: Dr
First Name: Helen
Surname: Vosper
Position: Lecturer, Teaching fellow
Telephone: +44 (0) 1224 262503
Email:
ORCID: ORCID Icon http://orcid.org/0000-0001-7796-5183

LinkedIn link coming soon

Roles and Responsibilities

Key research interests

Dr Vosper’s current research interests lie in the areas of:

  • Molecular mechanisms of atherosclerosis
  • Systemic inflammation
  • Rheumatoid arthritis
  • Metabolic disease
  • PPARs

Current research

Dr Vosper is an active researcher and an established member of the Institute for Health and Wellbeing Research. Her research skills include working with cell cultures, molecular biology, Western blotting and immunohisto/cytochemistry and has access specialised research facilities including real-time PCR. She is an active member of both the assessment board and the course design team for the PgCert/PgDip/MA Higher Education Learning and Teaching programme run by the University.

Teaching Interests

Dr Vosper is a fellow of the Higher Education Academy, an organisation that works with UK universities in developing and disseminating evidence-informed practice.

Key Publications

  1. Vosper H. The prevention of atherothrombotic events in adults with acute coronary syndromes. Clin Med Rev Vasc Health 2011; 3: 117-139
  2. Vosper H. Extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parameters. Clin Med Insights: Cardiology 2011; 5: 85-101
  3. Vosper H, Lipid regulation with niacin extended-release (Niaspan-RTM). Clin Med Rev Vasc Health 2011; 3: 1-18
  4. Vosper, H. (2009). Staff and student perceptions of pharmacy final year research projects. Pharmacy Education 9(1): 11-17
  5. Vosper, H. (2009). Niacin: A re-emerging pharmaceutical for the treatment of dyslipidaemia. Br J Pharmacol 158: 429-441
  6. Vosper, H., Khoudoli, G.A. and Palmer, C.N.A. The peroxisome proliferator activated receptor d is required for the differentiation of THP-1 monocytic cells by phorbol ester. Nuclear Receptor (2003) 1(1): 9
  7. Young, V., Vosper, H. , Ho, M., Belch, J.J.F. and Palmer, C.N.A. Elevated expression of the genes encoding TNF- a and thromboxane synthase in leukocytes from patients with systemic sclerosis. Rheumatology (2002) 41(8): 869-75
  8. Vosper, H. , Khoudoli, G.A., Graham, T.L. and Palmer, C.N.A. Peroxisome proliferator activated receptor agonists, hyperlipidaemia and atherosclerosis. Pharmacol. Therapeut. (2002) 95: 47-62
  9. Vosper, H. , Patel, L., Graham, T., Khoudoli, G.A., Hill, A., Macphee, C.H., Pinto, I., Smith, S.A., Suckling, K.E., Wolf, C.R. and Palmer, C.N.A. The peroxisome proliferator activated receptor d promotes lipid accumulation in human macrophages. (2001) J. Biol. Chem. 276(47): 44258-44265
  10. Palmer, C.N., Gustafsson, M.C., Dobson (Vosper), H. , von Wachenfeldt, C. and Wolf, C.R. Adaptive responses to fatty acids are mediated by regulated expression of cytochromes P450. Biochem. Soc. Trans. (1999) 27(4): 374-8
  11. D’Arrigo, C., Burl, S., Withers, A.P., Dobson, H. , Black, C. and Boxer, M. TGF- b 1 binding protein-like modules of fibrillin-1 and –2 mediate integrin-dependent cell adhesion. Connect. Tissue Res. (1998) 37(1-2): 29-31
  12. Dobson (Vosper) H, Pignatelli M, Hopwood D, D'Arrigo C. Cell adhesion molecules in oesophageal epithelium. Gut. 1994 Oct; 35 (10):1343–1347